For a few months, we’ve been hearing about IBM Watson Health’s plan to open a new headquarters in the Boston area. On Thursday, the business unit held an event at its new office and announced some partnerships, as well as an important first hire in Cambridge, MA. First, the people news: Deborah DiSanzo (pictured) is … Continue reading “IBM Watson Health Taps Ex-Philips CEO as GM, Touts New Partners”
Category: Boston
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard
There’s a messenger RNA battle brewing in Cambridge, MA. CureVac, a Germany-based mRNA company spun out of the University of Tubigen 15 years ago, said this morning that it’s opening up a U.S. hub in Cambridge. Karen Slobod, a former Novartis Vaccines executive, will head the new outpost, whose focus will be developing mRNA-based prophylactic … Continue reading “CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard”
Intact Medical Lands $750,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2a97f339-f606-4d3d-8831-2b7349dd1f60 Date 9/10/2015 Company Name Intact Medical Mailing Address 550 Cochituate Road Framingham, MA 01701 USA Company Description Intact Medical Corporation is dedicated to developing and distributing minimally invasive devices for the excision of breast tissue for diagnostic and therapeutic applications. Intact Medical designs, develops and markets tissue excision systems. Website http://www.intactmedical.com … Continue reading “Intact Medical Lands $750,000 New Funding”
GroupZOOM Obtains $1,475,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f8c7f429-a6e0-4a90-9e2c-7932438cb25d Date 9/10/2015 Company Name GroupZOOM Mailing Address 283 Newbury Street Boston, MA 02115 USA Company Description GroupZOOM Inc. operates as a pop-up mass transit network that provides a platform for customers to purchase tickets by utilizing vendors to complete trips. The company offers tickets directly to consumers on pop-up transportation networks. … Continue reading “GroupZOOM Obtains $1,475,000 New Financing Round”
VCharge Garners $256,536 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8cfa9d9f-581d-450f-8287-ad3e67e1f58a Date 9/10/2015 Company Name VCharge Mailing Address 235 Promenade Street Providence, RI 02908 USA Company Description VCharge uses decentralized, market-based principles to enable residential electric heaters, electric cars, and other transactive loads with embedded storage to engage in rapid demand response. VCharge technology brings real value to utilities, grid operators, and … Continue reading “VCharge Garners $256,536 New Funding”
netBlazr Obtains $300,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=48236383-86d1-48b6-81a5-d2d9d8eb57c9 Date 9/10/2015 Company Name netBlazr Mailing Address 218 Lincoln Street Allston, MA 02134 USA Company Description netBlazr is a locally-owned business that offers nothing but net, an Internet connection that is reliable and affordable and nothing else. No gimmicks, games, or tricks. Website http://www.netblazr.com Transaction Type Venture Equity Transaction Amount $300,000 … Continue reading “netBlazr Obtains $300,000 New Funding Round”
Stealthy Boston-Area Startup DOTS Devices Raises $8M
DOTS Devices, a stealthy new startup based outside of Boston, has raised about $8 million in equity and other securities, according to a document filed with the SEC today. The company could raise another $500,000 in this funding round, as the SEC filing shows a total offering amount of $8.5 million. A Google search didn’t … Continue reading “Stealthy Boston-Area Startup DOTS Devices Raises $8M”
From CustomMade to ButcherBox: A Serial Entrepreneur’s Journey
Mike Salguero’s story is a sign of the times. In the tech startup world, sometimes you go big. And sometimes you go home—and reinvent yourself with help from friends and industry experts. Salguero is the co-founder and former CEO of CustomMade, an online marketplace for crafts and home décor. The Boston-area company raised about $25 … Continue reading “From CustomMade to ButcherBox: A Serial Entrepreneur’s Journey”
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug
It’s unclear if Biogen was one of the unnamed bidders that lost out on Receptos a few months ago. But a deal the Cambridge-based company made this morning for a drug that would directly compete with Receptos sure makes it seem that way. Biogen (NASDAQ: [[ticker:BIIB]]) this morning paid $60 million up front for worldwide … Continue reading “Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug”
Apperian Raises $12M to Continue Momentum in Enterprise Mobility
Sometimes tech companies must raise venture capital out of necessity, in order to keep the business afloat until they get enough cash flowing in from customers to survive. Other times, companies have the luxury of choosing to raise money from investors to accelerate already-strong sales growth. The latter is the position Boston-based Apperian says it … Continue reading “Apperian Raises $12M to Continue Momentum in Enterprise Mobility”
Apperian Lands $12,382,996 Series C Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=885c407f-8ddf-433e-9022-81628f53e2cd Date 9/9/2015 Company Name Apperian Mailing Address 321 Summer Street Boston, MA 02210 USA Company Description Apperian is the industry’s #1 mobile application management platform and enterprise app store for delivering apps to 100% of your targeted users. We make it easy for you to secure and deploy mobile apps to … Continue reading “Apperian Lands $12,382,996 Series C Financing”
Loci Controls Lands $1,009,999 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e4a47cd7-6725-4be1-a5fc-881359c3dd8e Date 9/9/2015 Company Name Loci Controls Mailing Address 28 Dane Street Somerville, MA 02143 USA Company Description Loci Controls maximizes revenue for landfill gas to energy projects by using wireless sensors to monitor & control gas collection. Website http://www.locicontrols.com Transaction Type Venture Equity Transaction Amount $1,009,999 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Loci Controls Lands $1,009,999 New Financing”
Proteostasis Therapeutics Lands $37,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb3c3e7f-14e2-4e07-a288-8cbf30e3103a Date 9/9/2015 Company Name Proteostasis Therapeutics Mailing Address 200 Technology Square 4th Floor Cambridge, MA 02139 USA Company Description Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases. Website http://www.proteostasis.com … Continue reading “Proteostasis Therapeutics Lands $37,000,000 Series B Funding”
Common Sensing Receives $850,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=40c38152-1665-4b7a-8f71-9982b4b2cc82 Date 9/9/2015 Company Name Common Sensing Mailing Address 288 Norfolk St. Cambridge, MA 02139 USA Company Description Common Sensing Inc. manufactures a diabetes management product. The company offers an insulin pen cap that records a person’s insulin intake information and transmits it to a mobile phone or a connected glucose meter. … Continue reading “Common Sensing Receives $850,000 New Round”
With New Data, Highs and Lows For Akebia, Flexion, Tetraphase
Want to invest in biotech? Data released this afternoon from three Boston-area biotechs—Tetraphase Pharmaceuticals, Flexion Therapeutics, and Akebia Therapeutics—show just how big the risks and rewards can be. First, the bad news. Tetraphase (NASDAQ: [[ticker:TTPH]]) and Flexion (NASDAQ: [[ticker:FLXN]]) both reported that their experimental drugs failed clinical trials, and both were punished by public investors. … Continue reading “With New Data, Highs and Lows For Akebia, Flexion, Tetraphase”
How to Succeed in the Second Digital Era
Blockbuster. Borders. The U.S. Postal Service. These once-dominant entities, and many more, have all been victims of disruptive tech. Although it’s too early to sound the death knell for taxis, it’s also too late to say that ridesharing companies like Uber and Lyft are a flash in the pan. The disruptive change they represent is … Continue reading “How to Succeed in the Second Digital Era”
Healthcare Summit 2015
What’s next in the healthcare revolution? Join Xconomy for our third annual Boston Healthcare Summit featuring leaders in personalized medicine and genomics, health IT, big data, venture capital, and more. Together, we’ll chart the future of medicine and health and look for entrepreneurial solutions to the challenges facing our healthcare system. #xconhealth For full information, … Continue reading “Healthcare Summit 2015”
NFL Lab Report: Detroit’s Xenith Makes Top-Rated Football Helmet
The topic of football-related brain injuries has captured national attention as doctors and researchers learn more about the kind of long-term damage sustained by players in the rough-and-tumble sport. There’s even a movie scheduled to hit theaters later this year called “Concussion,” which stars Will Smith as Dr. Bennet Omalu, the real-life forensic neuropathologist who … Continue reading “NFL Lab Report: Detroit’s Xenith Makes Top-Rated Football Helmet”
CommScope Adds Airvana to Boost Indoor Wireless Offerings
CommScope, a company that provides telecommunications equipment for wired and wireless networks, has reached an agreement to acquire Airvana to beef up its capabilities supporting indoor wireless coverage. Hickory, NC-based CommScope (NASDAQ: [[ticker:COMM]]) says it will finance the acquisition with cash, but disclosed no terms other than to say it aims to close the deal … Continue reading “CommScope Adds Airvana to Boost Indoor Wireless Offerings”
Inclusion in Tech Entrepreneurship: Meritocracy or Myth?
We’ve been hearing a lot about how the high-tech industry has been working to recruit more underrepresented minorities and women into its ranks, without much early success. Less than 2 percent of the employees at Facebook, Google, and Twitter are African-American, according to the companies’ Equal Employment Opportunity reports for 2014, released earlier this year. … Continue reading “Inclusion in Tech Entrepreneurship: Meritocracy or Myth?”
GSK Deepens Ties With Electro-Stim Startup SetPoint in $15M Funding
When GlaxoSmithKline started up a venture fund a few years to invest in electronic medicines—treatments that use electrical impulses, rather than manmade chemicals or protein drugs, to impact disease—a startup called SetPoint Medical was its first investment. A few years later, with SetPoint nearing a key clinical trial, the British drugmaker has deepened its ties … Continue reading “GSK Deepens Ties With Electro-Stim Startup SetPoint in $15M Funding”
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round
Crossover investors—institutions that back both public and private companies—have been piling money into biotechs over the past few years. Today you can add Selecta Biosciences to the list of crossover-cash recipients, and pencil the Watertown, MA-based company as a future IPO candidate to boot. Selecta, a developer of nanoparticle technology, has raised a $38 million … Continue reading “Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round”
9 Frothy Tech Sectors of 2015: Food Delivery, Fintech, Drones & More
There’s a point at which a technology market or sector feels overhyped and saturated. Sometimes it’s when the first $1 billion valuation is announced—or when venture capital starts flowing so freely that it seems due diligence is an afterthought. And it’s definitely when media start calling tech businesses “Uber for (fill in the blank).” In … Continue reading “9 Frothy Tech Sectors of 2015: Food Delivery, Fintech, Drones & More”
Selecta Biosciences Receives $38,000,000 Series E Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=701acdc0-0097-4a7d-8177-7c9c8b64c9b5 Date 9/8/2015 Company Name Selecta Biosciences Mailing Address 480 Arsenal St. Building One Watertown, MA 02472 USA Company Description Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Website http://www.selectabio.com … Continue reading “Selecta Biosciences Receives $38,000,000 Series E Round”
Harmonix Reloaded: Music Videogame Maker Raises $15M
[Updated, 9/8/15. See below] For a 20-year-old company, Harmonix Music Systems sure looks like a startup. Now the Boston-based videogame maker, best known for the Guitar Hero and Rock Band franchises, has raised $15 million in new equity funding, according to a regulatory filing. The company isn’t talking yet, but the presence of venture capitalists … Continue reading “Harmonix Reloaded: Music Videogame Maker Raises $15M”
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More
What summer doldrums? It’s still not even Labor Day, yet the deals are already coming fast and furious. So fire up the grill and read on for some Series A rounds, crossover investments, data readouts, option-to-buy deals and more. —As Xconomy reported this week, a stealthy Cambridge, MA-based startup called X4 Pharmaceuticals raised a $37.5 … Continue reading “East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More”
Boston Tech Roundup: Databox, Ascent, LogMeIn, & More
There have been so many big headlines coming out of Boston this week—OK, really just one, about Tom Brady—that it’s been easy to miss some of them. With that in mind, here’s a roundup of some technology news of import: —Databox, a Boston company that helps marketers and managers track data from services such as … Continue reading “Boston Tech Roundup: Databox, Ascent, LogMeIn, & More”
Grove Labs Secures $1,791,413 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb6a6a79-c471-46b0-804e-44789617c72e Date 9/4/2015 Company Name Grove Labs Mailing Address 28 Dane Street Somerville, MA 02143 USA Company Description At Grove Labs, we believe that everybody on the planet deserves access to healthy, local, and sustainably grown food. We’re frustrated with the current state of food & agriculture, so we’re empowering people to … Continue reading “Grove Labs Secures $1,791,413 New Financing Round”
Exosome Diagnostics Lands $17,600,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4548458f-fd30-4e2b-8829-c41a2e5f6670 Date 9/4/2015 Company Name Exosome Diagnostics Mailing Address 840 Memorial Drive Cambridge, MA 02139 USA Company Description Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids. Website http://www.exosomedx.com Transaction Type Venture Equity Transaction Amount $17,600,000 Transaction Round Series B Proceeds Purposes These funds also will enable … Continue reading “Exosome Diagnostics Lands $17,600,000 Series B Round”
What Bubble? Techstars Boston Keeps Trying to Build Real Businesses
If you cover the technology startup industry, two words you are getting sick of seeing are “bubble” and “unicorn.” In place of the former, you are hearing more about a coming “correction” in valuations and so forth. In place of the latter, you mostly get people shaking their heads at what the term even means. … Continue reading “What Bubble? Techstars Boston Keeps Trying to Build Real Businesses”
Sage Points to Tremor Data to Back Up “De-Risked” Neuro Drug Plan
Companies are always looking to increase their odds of success, and Sage Therapeutics believes it’s come up with a clinical strategy to take some risk out of a risky business. Sage (NASDAQ: [[ticker:SAGE]]) today is reporting the results of a small, exploratory study of its lead drug, SAGE-547, in patients with essential tremor, a neurological … Continue reading “Sage Points to Tremor Data to Back Up “De-Risked” Neuro Drug Plan”
Censio, Led by Ex-Zipcar CEO, Brings Mobile Tech to Car Insurance
In the business of connected cars, at least one clear market has emerged: insurance. Today a Boston startup is taking a big step in that market. Censio, which has been growing quietly next to the Harvard Innovation Lab, said Wednesday it has formed a partnership with Progressive Insurance to develop a mobile app to monitor … Continue reading “Censio, Led by Ex-Zipcar CEO, Brings Mobile Tech to Car Insurance”
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo
There is no single race in gene therapy, or gene editing for that matter, more competitive than the one between companies trying to create treatments for hemophilia. And if one of its entrants, Sangamo Biosciences, is going to come out on top, it’ll likely have to do it without the help of Shire. Sangamo Biosciences … Continue reading “Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo”
Infinite Analytics Secures New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1829b79c-761d-4da9-9459-b09c08b4ce1b Date 9/2/2015 Company Name Infinite Analytics Mailing Address 222 3rd St. Cambridge, MA 02141 USA Company Description Infinite Analytics is the most advanced predictive marketing and analytics company. Co-founded by two MIT graduates, it began in a class taught by Sir Tim Berners-Lee, the inventor of the World Wide Web. Website … Continue reading “Infinite Analytics Secures New Funding Round”
Ivenix Garners $42,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=58db5cf4-ce08-4946-8af9-c61ae05ad595 Date 9/2/2015 Company Name Ivenix Mailing Address 21 Water Street 4th Floor Amesbury, MA 01913 USA Company Description The Ivenix Infusion Management System is built as an information system that operates within an infusion device. Using technologies similar to a Smartphone, it manages patient-specific infusion information so that it will always … Continue reading “Ivenix Garners $42,000,000 New Funding”
Renaissance, MVCA Program Lures Half-Dozen Investors to Michigan
Though Michigan’s startup community has experienced a ton of growth in the past 10 years, the state remains a place that is “underserved” when it comes to investment capital, says Chris Rizik, CEO and fund manager at Renaissance Venture Capital. With that in mind, Renaissance partnered with the Michigan Venture Capital Association for the past … Continue reading “Renaissance, MVCA Program Lures Half-Dozen Investors to Michigan”
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer
Several years ago, Genzyme developed a drug called plerixafor (Mozobil) that’s used to help with bone marrow transplants. Now a group of folks that helped push that drug forward have reunited for a new effort—to use a similar type of therapy for solid tumors and rare diseases. As Xconomy reported earlier today, X4 Pharmaceuticals was … Continue reading “Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer”
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+
Former Genzyme CEO Henri Termeer has been active as an advisor and investor in the Boston biotech scene the past few years, forming ties with companies like Moderna Therapeutics, Lysosomal Therapeutics, Aura Biosciences, and others. The latest startup to add to his list is X4 Pharmaceuticals, which apparently has raised $37.5 million, according to a … Continue reading “Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+”
At Summer’s End, Can Crossover Winds Stay At Biotech’s Back?
For certain parts of the population, “summer” is a verb, and in the U.S., one does it until Labor Day. One more week, then, before sunburned financial types return to their desks and biotech IPO hopefuls hit the road to plead their cases. Whether August’s market volatility continues its stomach-churning ways or recedes in September’s … Continue reading “At Summer’s End, Can Crossover Winds Stay At Biotech’s Back?”
CRISPR Cash: Intellia The Latest Gene-Editing Firm To Nab Big Money
As top scientists head toward a summit later this year to hammer out rules governing the use of gene editing, companies developing one form of the technology, known as CRISPR-Cas9, for human medicine continue to raise cash hand over fist. The latest is Intellia Therapeutics, of Cambridge, MA, which announced today a $70 million round … Continue reading “CRISPR Cash: Intellia The Latest Gene-Editing Firm To Nab Big Money”
SciAps Lands $4,300,003 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b2f1b29-bc88-4e52-b970-7d7442285fb8 Date 9/1/2015 Company Name SciAps Mailing Address 2 Constitution Way Woburn, MA 01801 USA Company Description SciAps, Inc., is a Boston-based instrumentation company specializing in portable analytical instruments. Our mission is to provide durable, field-tested, portable instruments to identify any compound, any mineral, any element — anyplace on the planet. Website … Continue reading “SciAps Lands $4,300,003 New Round”
Intellia Therapeutics Receives $70,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f884d753-16df-4b44-bde3-8854ed73aba7 Date 9/1/2015 Company Name Intellia Therapeutics Mailing Address 130 Brookline Street Cambridge, MA 02139 USA Company Description Intellia Therapeutic’s core mission is to lead the industry in therapeutic gene editing, utilizing the promise of the CRISPR/Cas9 technology. We are solely focused on the research and clinical development of gene editing therapies … Continue reading “Intellia Therapeutics Receives $70,000,000 Series B Financing Round”
5 Questions to Ask Before Investing in People or Technology
Congratulations. Your startup made it through its first challenging years, and you’re seeing positive returns. But, there’s always room to grow. Is it time to hire more salespeople, or should you invest in customer relationship management (CRM), productivity software, or another technology that can improve your business? The choice between putting money into technology or … Continue reading “5 Questions to Ask Before Investing in People or Technology”
Out of the Lab and Into the Newsroom
Information and registration here. Organized by JLABS @LabCentral. From the website: You’ve got your cutting-edge technology, you’ve raised money, and your company is making great headway on the R&D front. You’re ready to bring your company out of stealth mode and into the limelight, but what’s the next step? Media is a critical venue to … Continue reading “Out of the Lab and Into the Newsroom”
MassTLC Leadership Awards
Information and registration here. From the website: “The Massachusetts Technology Leadership Awards is the Commonwealth’s most prestigious tech awards program, dubbed the “Academy Awards” of tech. The program kicks off each April with a nomination period and culminates in September with an annual Awards Gala that draws top executives and teams from companies throughout the … Continue reading “MassTLC Leadership Awards”
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug
New drugs for fibrosis, an internal, often deadly type of scarring, have become the centerpiece of a number of biotech deals over the past few years. The latest just crossed the wires this morning, as Bristol-Myers Squibb has just nabbed an option to buy Promedior, of Lexington, MA. Bristol-Myers (NYSE: [[ticker:BMY]]) is paying $150 million … Continue reading “Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug”
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher
Just how far has Amicus Therapeutics come in two years? In 2013, the Cranbury, NJ-based company was reeling from a trial failure and restructuring to conserve cash. Now, it’s eyeing its first drug approval and buying a startup in a nine-figure deal. Amicus (NASDAQ: [[ticker:FOLD]]) this morning is announcing the acquisition of Durham, NC-based Scioderm. … Continue reading “With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher”
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer
If you tried to count on one hand the number of New York City biotech startups to get a substantial funding round this year, you’d probably have a few fingers left over. A stealthy startup out of Rockefeller University named Rgenix is one of the lucky few to score a significant haul, and today it’s … Continue reading “In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer”
Women, Get Off the Sidelines and Invest
In my travels across the country, I meet successful women with the means and motivation to make a difference in our communities—and in our world. We don’t think twice about writing a check to a worthy foundation, buying a table at a charity gala, or volunteering on a committee. We know the “rubber chicken” circuit … Continue reading “Women, Get Off the Sidelines and Invest”
New Apps, Management Software Seeping In as Old Industries Digitize
John Van Siclen recalls driving around last year in the middle of nowhere, Wisconsin, to visit a large retailer. The meeting was off the beaten path for the Dynatrace CEO, but not just in the physical sense. His Waltham, MA-based company makes software that helps businesses run their digital operations. Over the years, Dynatrace has … Continue reading “New Apps, Management Software Seeping In as Old Industries Digitize”